As Covid-19 cases peak, a virus once again takes advantage of human instinct
The natural response to a disaster is to at first believe that it is not…
Author: STAT
STAT Plus: Pharmalittle: NIH may own patents for the Moderna Covid-19 vaccine; ICER boosts recommended price for remdesivir
Hello, everyone, and how are you this morning? Another balmy day is unfolding here on…
Hospitals see shortages of a cheap steroid that one study says helps Covid-19 patients
After preliminary release of a study found that a cheap steroid reduced deaths by a…
Opinion: This is supposed to be telemedicine’s time to shine. Why are doctors abandoning it?
Telemedicine — the delivery of care by a clinician in one location to a patient…
.jpg)
Opinion: Pandemic politics: What leaders should — and shouldn’t — learn from Napoleon
Some leaders use pandemics and other crises to advance themselves and their own ends. Others…
Among people facing food insecurity, researchers find a hidden health issue: eating disorders
When Carolyn Black Becker, a psychologist who studies eating disorders, used to explain her research…
STAT Plus: A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial
Two years ago, French regulators made a surprising decision, overruling one of their own expert…
STAT Webinar: Targeted cancer drugs: What’s on the market? What’s in the pipeline?
Editor’s note: A recording of the webinar presentation is included below. While immunotherapies get most…
STAT Plus: Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients
Federal officials on Wednesday alleged that Regeneron Pharmaceuticals (REGN) donated tens of millions of dollars…
STAT Plus: Engineering a better immunotherapy to outwit cancer — and launch a biotech
Tweaking an immune cell called interleukin-18 can overcome tumors that lure it into binding with…
Health officers sound alarm as California economy reopens
Health officials in a San Francisco Bay Area county that was among the most aggressive…
STAT Plus: A preliminary new method could restore the brain cells Parkinson’s disease patients lost
Researchers developed a new method for transforming brain cells that can completely eliminate Parkinson’s disease…
STAT Plus: Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: Yumanity Therapeutics, Merck strike deal aimed at developing new medicines for neurodegenerative disease
Yumanity Therapeutics, a small neuroscience-focused startup co-founded by longtime biotech executive Tony Coles, is pairing…
Opinion: Treatment barriers create racial disparities in cancer care. They need to come down
Every American is entitled to equitable access to life, liberty, and the pursuit of happiness….
An app for football fans became a digital contact tracing tool — and could be a litmus test for Covid-19 technology
Software engineer Tim Brookins didn’t build his Bison Tracker app with the coronavirus pandemic in…
STAT Plus: FDA urged to heighten safety warnings on common type 2 diabetes drugs
A consumer advocacy is urging the Food and Drug Administration to heighten warnings about a…
Top U.S. health officials say they were never told to slow down Covid-19 testing, contradicting Trump
WASHINGTON — Four key government health care officials said Tuesday that despite recent remarks from…
STAT Plus: STAT+ Conversations: The Readout LOUD, Live!
Editor’s note: The livestream of this conversation will be embedded below at 1 p.m. ET. …
STAT Plus: As approval decision nears, fate of Intercept’s NASH drug clouded by murky FDA review delays
On Friday, the Food and Drug Administration is supposed to announce its decision on whether…
STAT Plus: Pharmalittle: Sanofi steps up Covid-19 vaccine efforts; has a successor to FDA’s Janet Woodcock been found?
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT Plus: Myovant endometriosis drug meets its goal in a second late-stage trial, company says
A combination pill from Myovant Sciences met its primary goal of reducing pain from endometriosis,…
STAT Plus: Sana Biotechnology, the secretive startup, lays (some) cards on the table
After years of rumors, Sana Biotechnology is officially biotech’s newest unicorn. The company announced Tuesday…
Opinion: Human challenge trials with live coronavirus aren’t the answer to a Covid-19 vaccine
More than 25,000 people have volunteered so far to be infected with the novel coronavirus…
STAT Plus: The new Janet: The FDA turns to a quiet problem-solver who brings expertise — and a little controversy
WASHINGTON — Janet Woodcock, one of the FDA’s most powerful regulators, has an almost mythic…
STAT Plus: After a bribery scandal in China, GSK found a suspected whistleblower. The real one is still waiting in the shadows
Alarmed that colleagues were bribing Chinese doctors and giving kickbacks to hospital workers to boost…
Sanofi, a straggler in the Covid-19 vaccine race, accelerates its plans
The drug maker Sanofi Pasteur has been more cautious than some of its rivals in…
Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs
Amid ongoing concern that Covid-19 therapies and vaccines may be unaffordable, a bipartisan group of…
STAT Plus: A Chinese drug maker scores a big clinical trial win with a novel diabetes therapy
Two years ago, Hua Medicine turned to the public markets to help finance its ambitious…
STAT Plus: Pharmalittle: Will a Covid-19 vaccine protect the elderly? Generic remdesivir to cost up to $79 a dose
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Lack of rapid diagnostic tools contributes to Covid-19 deaths
SARS-CoV-2, a coronavirus that humans have never before encountered, is causing hundreds of thousands of…
Second deadliest Ebola outbreak on record is days from being declared over
It hasn’t been the longest, nor has it been the deadliest. But the Ebola outbreak…
STAT Plus: Can a prescription video game actually make money? Akili is about to find out
Akili Interactive Labs proved last week that it could convince the Food and Drug Administration…
Opinion: Covid-19 could cause a mental health crisis. It can also spark post-traumatic growth
Some experts are warning of a looming mental health crisis in the wake of the…
As Covid-19 devastates communities of color, the government’s minority health experts are conspicuously quiet
WASHINGTON — Four months into a pandemic that has disproportionately devastated Black, Latino, and Native…
STAT Plus: A crucial study of Bellus Health’s chronic cough drug reads out soon. Here’s what you need to know
Bellus Health, a small Canadian drug maker, is seeking to develop a potential blockbuster medicine…
Opinion: Celebrate fathers by including them in family health research, especially about Covid-19
Covid-19 is freaking out fathers. And rightly so. Whether it’s an expectant father trying not…
Opinion: The Trump rally in Tulsa is a recipe for disaster
President Trump is set to hold a rally Saturday evening inside the 19,199-seat Bank of…
STAT Plus: Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Finch touts positive results for its microbiome pill for C. diff infections
Three-quarters of the people who got Finch Therapeutics’ microbe-based pill for potentially deadly C. difficile…
Opinion: Account for gender/sex to make personal protective equipment safer for women
Covid-19 is not a gender- or sex-neutral killer. Men are more likely than women to…
Opinion: How many needless Covid-19 deaths were caused by delays in responding? Most of them
More than 120,000 Americans have now perished from Covid-19, surpassing the total number of U.S….
He speaks at Black churches about genetics — and has some ideas about how to fix his field’s diversity problem
Over the past few weeks, 23andMe and other genetic testing companies have made headlines for…
Ignoring cancer care now may trade one public health crisis — Covid-19 — for another, NCI chief warns
Ned Sharpless is worried. The director of the National Cancer Institute believes the Covid-19 pandemic…
STAT Plus: A ‘semi-wartime’ effort: Thermo Fisher COO on adapting the business to a Covid-19 world
Way back in January, Thermo Fisher Scientific (TMO), the world’s largest maker of scientific tools,…
.jpg)
Listen: The latest on treating Covid-19, vaccine politics, and diversifying genetics
Can a vaccine be an October surprise? Are journal publishers running a racket? And why…
Trump says Covid-19 is ‘dying out.’ Experts fear his dismissiveness could prolong the crisis
WASHINGTON — The White House is taking a new position on the coronavirus pandemic: a…
STAT Plus: Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach
The icy relationship between Vertex Pharmaceuticals (VRTX) and the Canadian government is showing signs of…
STAT Plus: New findings about little-studied cellular compartments could help make chemo more effective
Getting the right drug to the right place at the right time has been the…
STAT Plus: Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests
For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for…